As of January 2025, Hikma Pharmaceuticals has a market cap of $5.52B. This makes Hikma Pharmaceuticals the world's 2471th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $5.51B | 11.07% |
2023 | $4.96B | 15.27% |
2022 | $4.31B | -30.06% |
2021 | $6.16B | -11.87% |
2020 | $6.99B | 26.47% |
2019 | $5.52B | 16.03% |
2018 | $4.76B | 51.32% |
2017 | $3.15B | -40.10% |
2016 | $5.25B | -17.73% |
2015 | $6.38B | 16.27% |
2014 | $5.49B | 64.78% |
2013 | $3.33B | 57.82% |
2012 | $2.11B | 22.74% |
2011 | $1.72B | -23.60% |
2010 | $2.25B | 59.12% |
2009 | $1.42B | 45.71% |
2008 | $971.13M | -26.04% |
2007 | $1.31B | 29.57% |
2006 | $1.01B | -9.76% |
2005 | $1.12B | - |